US Stock Market Move | Regencell Bioscience Holdings Ltd. (RGC.US) plummeted sharply by over 23%, with its biggest increase of 6681% this year.
On Monday, Renascent Genomic Center (RGC.US) dropped more than 23%, with its stock price hovering dangerously close to $300.
On Monday, Regencell Bioscience Holdings Ltd. (RGC.US) plummeted over 23%, with the stock price almost breaching $300. The stock had been on a continuous rise previously, with the highest increase of 6681% within the year. It is reported that Regencell Bioscience Holdings Ltd. is an early-stage biotech company specializing in traditional Chinese medicine treatments for neurological cognitive disorders and degenerative diseases.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
